Home> Products> liver enzyme profile enhancement

{ "products": [ { "_id": "6815f503b631af66ff8479d0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ATOVASTRIN EZ F", "description": "ATOVASTRIN EZ F is a scientifically formulated triple-action lipid-lowering medication designed for the comprehensive management of dyslipidemia and mixed hyperlipidemia. Combining Atorvastatin, Fenofibrate, and Ezetimibe, this powerful therapy targets multiple pathways of cholesterol and triglyceride metabolism. It is ideal for patients with elevated LDL cholesterol, triglycerides, and low HDL levels, helping reduce cardiovascular risk effectively.\n\nKey Ingredients\nAtorvastatin Calcium (10 mg):\nA statin that inhibits HMG-CoA reductase, reducing cholesterol production in the liver and lowering LDL (bad cholesterol) and total cholesterol levels.\n\nFenofibrate (160 mg):\nA fibrate that activates peroxisome proliferator-activated receptors (PPAR-alpha) to enhance the breakdown of triglycerides and increase HDL (good cholesterol) levels.\n\nEzetimibe IP (10 mg):\nA cholesterol absorption inhibitor that works at the intestinal level to block the absorption of cholesterol from food, further lowering blood cholesterol.\n\nKey Benefits\nComprehensive control of LDL, HDL, and triglyceride levels\n\nReduces total cholesterol and prevents the buildup of arterial plaque\n\nImproves cardiovascular outcomes in patients at high risk\n\nTargets cholesterol absorption, production, and clearance simultaneously\n\nBeneficial for patients with mixed dyslipidemia, metabolic syndrome, or diabetic dyslipidemia\n\nSupports long-term heart and blood vessel health\n\nHow Does It Work?\nATOVASTRIN EZ F works through a three-pronged mechanism to lower lipid levels:\n\nAtorvastatin blocks HMG-CoA reductase in the liver, reducing cholesterol synthesis and increasing LDL receptor activity to clear more cholesterol from the bloodstream.\n\nFenofibrate stimulates enzymes that enhance the oxidation of fatty acids and reduce triglyceride levels while increasing HDL.\n\nEzetimibe selectively inhibits the Niemann-Pick C1-Like 1 (NPC1L1) protein in the intestine, preventing dietary and biliary cholesterol absorption.\n\nTogether, these actions reduce LDL cholesterol, raise HDL, and lower triglycerides, offering complete lipid management.\n\nDirections for Use\nTake ATOVASTRIN EZ F exactly as prescribed by your physician.\n\nTypically, one tablet is taken once daily, preferably with or after a meal.\n\nSwallow the tablet whole with water — do not crush or chew.\n\nMaintain a low-fat, heart-healthy diet and follow regular exercise for best results.\n\nRegular monitoring of lipid profile, liver function, and renal function is advised during long-term use.\n\nDo not discontinue the medication without consulting your doctor.\n\nSide Effects\nLike all medications, ATOVASTRIN EZ F may cause some side effects, although not everyone experiences them.\n\nCommon Side Effects:\n\nHeadache\n\nMuscle pain or cramps\n\nDigestive disturbances (nausea, diarrhea, indigestion)\n\nFatigue\n\nMild elevation in liver enzymes\n\nRare but Serious Side Effects:\n\nRhabdomyolysis (muscle breakdown with dark urine and weakness)\n\nLiver toxicity\n\nPancreatitis\n\nGallstones (due to fenofibrate)\n\nAllergic reactions (rash, itching, swelling)\n\nSeek medical help immediately if you experience severe muscle pain, yellowing of eyes/skin, or signs of allergic reaction.", "price": 298.0, "discountamount": 90.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "allergic reaction", "dark urine", "renal function", "chew maintain", "meal swallow", "daily preferably", "physician typically", "fatty acids", "threepronged mechanism", "ldl hdl", "intestinal level", "comprehensive management", "triglyceride metabolism", "side effects", "atovastrin ez", "biliary cholesterol absorption", "cholesterol absorption inhibitor", "liver enzymes rare", "doctor side effects", "medications atovastrin ez", "work atovastrin ez", "reduce triglyceride levels", "results regular monitoring", "follow regular exercise", "lowfat hearthealthy diet", "intestine preventing dietary", "blood vessel health", "clearance simultaneously beneficial" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2100, "imageuri": "https://productimages.withfloats.com/actual/6815f505a654de67a62eb05a.png", "tileimageuri": "https://productimages.withfloats.com/tile/6815f505a654de67a62eb05a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-03T10:50:43.252Z", "updatedon": "2025-05-03T10:51:38.958Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/atovastrin-ez-f/2100", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Atrovastatin Calcium (10mg), Fenofibrate (160mg), Ezetimibe IP (10mg)", "category": "CARDIOLOGYRANGE", "tags": [ "Atorvastatin 10 mg and Fenofibrate 160 mg Tablet uses", "Atorvastatin 10 mg fenofibrate 160 mg side effects", "Atorvastatin 10 mg and Fenofibrate 160 mg brands", "Atorvastatin 10 Mg and Fenofibrate 160 mg Uses in Hindi", "Atorvastatin 10 mg and Fenofibrate 160 mg Price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6808ddcf5a26e4010ea41802", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Rosuvastatin (20mg), Clopidogrel (75mg)", "description": "REVOSTATIN CV 20 is a powerful combination therapy containing Rosuvastatin (20 mg) and Clopidogrel (75 mg), specifically formulated to manage high cholesterol levels and prevent cardiovascular events such as heart attacks and strokes. This dual-action tablet is commonly prescribed for individuals at high risk of atherosclerotic cardiovascular disease (ASCVD). It helps reduce LDL cholesterol, prevent plaque buildup, and inhibit blood clot formation, offering comprehensive protection for heart and blood vessel health.\n\n\nKey Ingredients:\n\n\nRosuvastatin (20 mg):.\nA potent statin (HMG-CoA reductase inhibitor) that lowers \"bad\" LDL cholesterol, raises \"good\" HDL cholesterol, and reduces triglyceride levels. It is effective in slowing down the progression of atherosclerosis and reducing the risk of cardiovascular complications.\n\nClopidogrel (75 mg):.\nAn antiplatelet agent that works by preventing blood platelets from clumping together, thereby reducing the risk of blood clots. It is especially beneficial for patients with a history of heart attack, stroke, or those who have undergone angioplasty or stent placement.\n\n\nKey Benefits:.\n\n\nEffectively lowers LDL cholesterol and triglyceride levels.\n\nIncreases HDL cholesterol to improve lipid profile.\n\nPrevents blood clots, reducing the risk of heart attack and stroke.\n\nOffers dual cardiovascular protection in a single daily dose.\n\nHelps patients with coronary artery disease or post-cardiac interventions.\n\nImproves long-term outcomes in patients with high atherosclerotic risk.\n\n\nHow Does It Work?\n\n\nREVOSTATIN CV 20 provides a two-fold mechanism of action:.\n\nRosuvastatin inhibits the HMG-CoA reductase enzyme in the liver, which is responsible for cholesterol production. By lowering LDL cholesterol and increasing HDL cholesterol, it reduces the formation of fatty deposits (plaques) in the arteries, thus improving blood flow and lowering cardiovascular risk.\n\nClopidogrel works by irreversibly inhibiting the P2Y12 component of ADP receptors on platelet surfaces, preventing platelet aggregation. This reduces the chance of clot formation, especially in narrowed arteries, and protects against thrombotic cardiovascular events.\n\nTogether, they offer a comprehensive cardiovascular defense, targeting both cholesterol levels and clot formation.\n\n\nDirections for Use:.\n\n\nTake REVOSTATIN CV 20 as directed by your doctor.\n\nTypically, the tablet is taken once daily, preferably in the evening.\n\nSwallow the tablet whole with a glass of water. Do not crush or chew.\n\nCan be taken with or without food.\n\nFollow a cholesterol-lowering diet and maintain an active lifestyle as advised.\n\nRegular monitoring of lipid levels, liver function, and platelet count may be necessary.\n\n\nSide Effects:.\n\n\nWhile REVOSTATIN CV 20 is generally well-tolerated, some individuals may experience side effects:.\n\nCommon Side Effects:.\n\nHeadache.\n\nMuscle pain or weakness.\n\nDizziness.\n\nNausea or abdominal discomfort.\n\nConstipation or diarrhea.\n\nEasy bruising or bleeding (due to Clopidogrel).\n\nSerious (but rare) Side Effects:.\n\nLiver enzyme elevation.\n\nMyopathy or rhabdomyolysis (severe muscle damage).\n\nSevere bleeding or gastrointestinal bleeding.\n\nAllergic reactions such as rash, itching, or swelling.\n\nThrombocytopenia (low platelet count).\n\nSeek immediate medical attention if you experience chest pain, severe muscle pain, unusual bleeding, or yellowing of the skin or eyes.", "price": 285.0, "discountamount": 86.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "dualaction tablet", "narrowed arteries", "medical attention", "rash itching", "bleeding due", "generally welltolerated", "side effects", "platelet count", "active lifestyle", "cholesterollowering diet", "food follow", "evening swallow", "daily preferably", "doctor typically", "revostatin cv 20", "adp receptors", "p2y12 component", "irreversibly inhibiting", "twofold mechanism", "undergone angioplasty", "antiplatelet agent", "commonly prescribed", "heart attacks", "high risk", "clot formation", "cholesterol production", "heart attack", "rosuvastatin 20 mg", "blood clots", "cholesterol levels", "high atherosclerotic risk", "reduces triglyceride levels", "clot formation directions", "heart attack stroke", "increasing hdl cholesterol", "lowering ldl cholesterol", "action rosuvastatin inhibits", "improving blood flow", "preventing blood platelets", "diarrhea easy bruising", "abdominal discomfort constipation", "weakness dizziness nausea", "advised regular monitoring", "thrombotic cardiovascular events", "fatty deposits plaques", "hmgcoa reductase enzyme", "coronary artery disease", "prevent cardiovascular events", "powerful combination therapy" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2088, "imageuri": "https://productimages.withfloats.com/actual/6808ddd1f5264360cb87dd17.png", "tileimageuri": "https://productimages.withfloats.com/tile/6808ddd1f5264360cb87dd17.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-04-23T12:32:15.95Z", "updatedon": "2025-04-23T12:35:58.359Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/rosuvastatin-20mg-clopidogrel-75mg-/2088", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "REVOSTATIN CV 20", "category": "CARDIOLOGYRANGE", "tags": [ "Rosuvastatin 10 mg Clopidogrel 75 mg brands", "Rosuvastatin 10 mg and Clopidogrel 75 mg Capsules", "rosuvastatin 20 + clopidogrel 75 brands", "rosuvastatin+clopidogrel brands in india", "Rosuvastatin 20 mg and Clopidogrel 75 mg Capsule uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67122b0ce42a258b4935925e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Pantoprazole (40 mg)", "description": "PANTOSTRUM IV INJECTION is a potent medication designed to manage acid-related disorders. This injectable formulation is particularly useful for patients who require immediate therapeutic intervention, such as those unable to take oral medications. Containing Pantoprazole (40 mg), a powerful proton pump inhibitor (PPI), PANTOSTRUM IV effectively reduces gastric acid secretion, providing relief from conditions such as gastroesophageal reflux disease (GERD) and peptic ulcers.\n\nThis product is administered intravenously, ensuring rapid onset of action, which is crucial in managing acute situations where oral administration may not be feasible.\n\n \nKey Benefits: \n \n\nRapid Relief: The intravenous formulation provides quick relief from acid-related symptoms, making it suitable for acute conditions.\n\nEffective for a Range of Conditions: PANTOSTRUM IV is beneficial for treating gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome.\n\nPrevents Recurrent Symptoms: Regular use can help prevent the recurrence of acid-related symptoms, improving the quality of life for patients with chronic conditions.\n\nSafe for Short-Term Use: While PPIs are typically used for longer durations, this injectable form is safe for short-term management in a hospital or clinical setting.\n\nWell-Tolerated: Most patients tolerate Pantoprazole well, with a favorable safety profile compared to other PPIs.\n\n \nHow Does It Work?\n \n\nPANTOSTRUM IV INJECTION contains Pantoprazole, which selectively inhibits the H+/K+ ATPase enzyme (the proton pump) located in the gastric parietal cells. By blocking this enzyme, Pantoprazole effectively reduces the secretion of gastric acid into the stomach. The decreased acid production alleviates symptoms associated with acid reflux and protects the gastric mucosa from damage due to excessive acid.\n\nThe rapid onset of action provided by the intravenous route makes it especially useful for patients experiencing severe symptoms or those in critical care situations, where immediate acid suppression is necessary.\n\n \nDirections for Use:\n \n\nAdministration: PANTOSTRUM IV INJECTION should be administered by a healthcare professional.\nDosage: The typical adult dosage is 40 mg, administered once daily. For certain conditions, higher dosages or more frequent administration may be necessary, as determined by a physician.\nInfusion Method: The injection should be diluted appropriately and infused slowly over 2-15 minutes, as recommended in the prescribing information.\nNote: Always follow the healthcare provider’s instructions regarding dosage and duration of therapy.\n\n \nSide Effects:\n \n\nWhile PANTOSTRUM IV INJECTION is generally well-tolerated, some patients may experience side effects. Common side effects include:\n\nHeadache: A frequent side effect, which may resolve on its own.\nDiarrhea: Some patients may experience gastrointestinal disturbances.\nNausea/Vomiting: Mild nausea or vomiting may occur in some individuals.\nDizziness: A sensation of light-headedness can occur but is usually transient.\nInjection Site Reactions: Pain or irritation at the injection site may happen but is generally mild.\nSerious Side Effects: Although rare, serious side effects may include severe allergic reactions, liver dysfunction, or kidney problems. Seek immediate medical attention if any severe symptoms occur.", "price": 56.5, "discountamount": 16.95, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "other PPIs", "Regular use", "Mild nausea", "rapid onset", "acid reflux", "quick relief", "Rapid Relief", "2-15 minutes", "Key Benefits", "Most patients", "peptic ulcers", "Short-Term Use", "higher dosages", "excessive acid", "gastric mucosa", "kidney problems", "Infusion Method", "severe symptoms", "acid production", "acute conditions", "clinical setting", "longer durations", "oral medications", "acute situations", "liver dysfunction", "intravenous route", "potent medication", "chronic conditions", "Recurrent Symptoms", "oral administration", "healthcare provider", "H+/K+ ATPase enzyme", "Common side effects", "typical adult dosage", "frequent side effect", "acid-related symptoms", "short-term management", "injectable formulation", "acid-related disorders", "gastric acid secretion", "gastric parietal cells", "prescribing information", "healthcare professional", "intravenous formulation", "frequent administration", "PANTOSTRUM IV INJECTION", "Injection Site Reactions", "critical care situations", "favorable safety profile", "severe allergic reactions", "Zollinger-Ellison syndrome", "immediate acid suppression", "rare, serious side effects", "immediate medical attention", "gastrointestinal disturbances", "powerful proton pump inhibitor", "gastroesophageal reflux disease", "immediate therapeutic intervention" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1993, "imageuri": "https://productimages.withfloats.com/actual/67122b10ce3b6899c42f8e60.png", "tileimageuri": "https://productimages.withfloats.com/tile/67122b10ce3b6899c42f8e60.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-10-18T09:31:56.085Z", "updatedon": "2024-10-18T09:31:56.085Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//pantoprazole-40-mg-/1993", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PANTOSTRUM IV INJECTION ", "category": "GASTROLOGYRANGE", "tags": [ "pantop injection i.v. or im", "Pantoprazole injection uses", "Pantoprazole IV infusion guidelines", "Pantoprazole injection 40 mg uses", "Pan 40 Injection im or IV", "Pantoprazole injection uses", "Pantop इंजेक्शन in Hindi", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662c4c88ecffe165c354dc1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VILDIABATE PIO ", "description": "VILDIABATE PIO \nVildagliptin 50 mg & Pioglitazone Hydrochloride 15 mg\nIntroduction to VILDIABATE PIO\nVILDIABATE PIO is a combination medication designed for the effective management of type 2 diabetes mellitus. It contains two active ingredients: Vildagliptin 50mg and Pioglitazone Hydrochloride 15mg. This dual-action formula targets different aspects of glucose regulation, providing comprehensive blood sugar control. It is used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nKey Components and Their Mechanisms\nVildagliptin 50mg\nVildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by:\n\nEnhancing Incretin Levels: Vildagliptin inhibits the DPP-4 enzyme, which degrades incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These hormones increase insulin secretion and decrease glucagon release in a glucose-dependent manner.\nImproving Postprandial Glucose Control: By enhancing the action of incretin hormones, Vildagliptin helps regulate blood sugar levels after meals.\nPioglitazone Hydrochloride 15mg\nPioglitazone is a thiazolidinedione that improves insulin sensitivity in muscle and adipose (fat) tissues. It works by:\n\nIncreasing Insulin Sensitivity: Pioglitazone enhances the body's response to insulin, allowing for better glucose uptake and utilization by cells.\nReducing Hepatic Glucose Production: Pioglitazone decreases the amount of glucose produced by the liver, helping to lower fasting blood sugar levels.\nBenefits of VILDIABATE PIO\nComprehensive Blood Sugar Control\nFasting and Postprandial Glucose Management: The combination of Vildagliptin and Pioglitazone effectively manages both fasting and postprandial (after-meal) blood sugar levels.\nImproved Insulin Sensitivity and Secretion: Vildagliptin enhances insulin secretion in response to meals, while Pioglitazone improves insulin sensitivity in peripheral tissues.\nAdditional Health Benefits\nLow Risk of Hypoglycemia: Vildagliptin has a low risk of causing hypoglycemia (low blood sugar) because it enhances insulin secretion only when blood glucose levels are elevated.\nCardioprotective Effects: Pioglitazone may provide additional cardiovascular benefits, such as improving lipid profiles and reducing inflammation, which can be beneficial for patients with diabetes who are at risk of cardiovascular diseases.\nWeight Management: While Pioglitazone may cause some weight gain due to fluid retention, Vildagliptin is generally weight neutral, balancing the overall effect on body weight.\nDosage and Administration\nRecommended Dosage\nDosage: The typical dosage of VILDIABATE PIO is one tablet taken once daily, preferably with a meal to enhance absorption and reduce gastrointestinal side effects.\nAdministration: Swallow the tablet whole with a glass of water. Do not crush, chew, or split the tablet unless advised by your healthcare provider.\nGuidelines for Optimal Use\nConsistent Use: For best results, take VILDIABATE PIO regularly at the same time each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regular monitoring of blood sugar levels is essential to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vildiabate-pio-134257\n", "price": 295.0, "discountamount": 88.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "diet", "Order", "meals", "EMAIL", "cells", "liver", "water", "glass", "GLP-1", "amount", "muscle", "adults", "Fasting", "adipose", "patients", "Low Risk", "exercise", "readings", "response", "Enhancing", "same time", "one tablet", "Mechanisms", "Increasing", "Guidelines", "absorption", "utilization", "Optimal Use", "information", "body weight", "Adjustments", "weight gain", "DPP-4 enzyme", "inflammation", "Introduction", "Vildagliptin", "Hypoglycemia", "sterispharma", "best results", "fat) tissues", "sterisonline", "CALL/WHATSAPP", "Administration", "VILDIABATE PIO", "glucose uptake", "Key Components", "Consistent Use", "treatment plan", "overall effect", "lipid profiles", "typical dosage", "Incretin Levels", "low blood sugar", "fluid retention", "glycemic control", "glucagon release", "DPP-4) inhibitor", "Weight Management", "insulin secretion", "incretin hormones", "different aspects", "thiazolidinedione", "peripheral tissues", "glucose regulation", "Regular monitoring", "healthcare provider", "dual-action formula", "insulin sensitivity", "blood glucose levels", "effective management", "dipeptidyl peptidase-4", "two active ingredients", "combination medication", "cardiovascular diseases", "Cardioprotective Effects", "type 2 diabetes mellitus", "meal) blood sugar levels", "glucose-dependent manner", "Recommended Dosage Dosage", "Pioglitazone Hydrochloride", "Additional Health Benefits", "Hepatic Glucose Production", "gastrointestinal side effects", "Postprandial Glucose Management", "comprehensive blood sugar control", "additional cardiovascular benefits", "Improving Postprandial Glucose Control", "glucose-dependent insulinotropic peptide" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1512, "imageuri": "https://productimages.withfloats.com/actual/667d3d8c5443982e2f655655.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d3d8c5443982e2f655655.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T08:28:56.298Z", "updatedon": "2024-06-27T10:23:02.274Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//vildiabate-pio-/1512", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VILDIABATE PIO ", "category": "DIABETIC RANGE", "tags": [ "vildagliptin metformin hydrochloride tablets uses", "vildagliptin + metformin + glimepiride combination", "vildagliptin 50 mg side effects", "vildagliptin and pioglitazone hydrochloride" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661ad3166170d1ff8cb4574", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TENELIGOLD PIO 20/15 ", "description": "TENELIGOLD PIO 20/15 \nTeneligliptin & Pioglitazone\nTENELIGOLD PIO 20/15 is a combination medication that contains Teneligliptin and Pioglitazone. It is primarily used in the management of type 2 diabetes mellitus, a condition characterized by high blood sugar levels due to insulin resistance or inadequate insulin production.\n\nTeneligliptin: Teneligliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by inhibiting the DPP-4 enzyme, which in turn enhances the levels of incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These hormones stimulate insulin secretion and inhibit glucagon release, leading to improved glucose control after meals.\n\nPioglitazone: Pioglitazone belongs to the thiazolidinedione class of medications. It works by improving insulin sensitivity in muscle and adipose (fat) tissues, reducing glucose production in the liver, and enhancing glucose uptake in peripheral tissues. This helps lower blood sugar levels and improves overall glycemic control.\n\nBenefits of TENELIGOLD PIO 20/15:\nComprehensive Glycemic Control: The combination of Teneligliptin and Pioglitazone addresses different aspects of glucose metabolism, providing comprehensive control over fasting and postprandial (after-meal) blood sugar levels.\n\nEnhanced Insulin Sensitivity: Pioglitazone improves insulin sensitivity in cells, allowing better utilization of glucose and reducing insulin resistance.\n\nIncretin Hormone Enhancement: Teneligliptin enhances the action of incretin hormones, which regulate insulin secretion and glucagon levels, leading to better glucose regulation after meals.\n\nCardioprotective Effects: Pioglitazone has been associated with cardiovascular benefits such as improved lipid profiles and reduced risk of cardiovascular events in some patients.\n\nHow to Use TENELIGOLD PIO 20/15:\nDosage: The typical dosage is one tablet taken orally once daily, usually with meals. Your healthcare provider will determine the appropriate dosage based on your medical condition and response to treatment.\n\nAdministration: Swallow the tablet whole with a glass of water. Do not crush, chew, or split the tablet unless advised by your doctor.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/teneligold-pio-20-15-134077", "price": 149.0, "discountamount": 44.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "risk", "turn", "Order", "EMAIL", "GLP-1", "water", "glass", "meals", "cells", "liver", "action", "muscle", "doctor", "adipose", "fasting", "patients", "response", "treatment", "one tablet", "management", "information", "medications", "utilization", "Pioglitazone", "postprandial", "fat) tissues", "DPP-4 enzyme", "sterispharma", "sterisonline", "CALL/WHATSAPP", "Teneligliptin", "teneligold-pio", "glucose uptake", "lipid profiles", "typical dosage", "Administration", "TENELIGOLD PIO", "glucagon levels", "glucose control", "glucagon release", "DPP-4) inhibitor", "incretin hormones", "medical condition", "different aspects", "insulin secretion", "glucose production", "insulin resistance", "appropriate dosage", "glucose metabolism", "glucose regulation", "peripheral tissues", "healthcare provider", "cardiovascular events", "comprehensive control", "combination medication", "dipeptidyl peptidase-4", "thiazolidinedione class", "cardiovascular benefits", "high blood sugar levels", "Cardioprotective Effects", "overall glycemic control", "type 2 diabetes mellitus", "meal) blood sugar levels", "Enhanced Insulin Sensitivity", "Incretin Hormone Enhancement", "inadequate insulin production", "Comprehensive Glycemic Control", "glucose-dependent insulinotropic peptide" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1480, "imageuri": "https://productimages.withfloats.com/actual/6661ad34c749b7962dbc4345.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661ad34c749b7962dbc4345.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:36:01.592Z", "updatedon": "2024-06-28T12:39:29.014Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/teneligold-pio-20-15-/1480", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TENELIGOLD PIO 20/15 ", "category": "DIABETIC RANGE", "tags": [ "TENELIGOLD PIO 20/15", "Teneligliptin", "Pioglitazone", "Teneligliptin uses", "Teneligliptin side effects", "Teneligliptin 20mg", "Teneligliptin+Metformin", "Teneligliptin 20 mg price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661a2708da3a81d5c6a169f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "STERIS SITAGLIPTIN 50 + METFORMIN 500 ", "description": "STERIS SITAGLIPTIN 50 + METFORMIN 500 \nSitagliptin (50mg) & Metformin HCI (500mg)\nIntroduction to STERIS SITAGLIPTIN 50 + METFORMIN 500\nSTERIS SITAGLIPTIN 50 + METFORMIN 500 is a combination medication that includes Sitagliptin 50mg and Metformin Hydrochloride 500mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Sitagliptin and Metformin, this medication offers comprehensive glycemic control, helping patients effectively manage their blood sugar levels.\n\nWhat are Sitagliptin and Metformin?\nOverview of Sitagliptin\nSitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that helps control blood sugar levels by enhancing the body's ability to regulate insulin after meals. It works by inhibiting the DPP-4 enzyme, which results in prolonged activity of incretin hormones that play a significant role in glucose metabolism.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. Metformin is a cornerstone in the management of type 2 diabetes due to its effectiveness and safety profile.\n\nBenefits of STERIS SITAGLIPTIN 50 + METFORMIN 500\nEffective Blood Sugar Management\nDual Mechanism of Action: Sitagliptin enhances insulin release and reduces glucagon levels after meals, while Metformin improves insulin sensitivity and reduces hepatic glucose production, providing comprehensive glycemic control.\nPostprandial and Fasting Glucose Control: This combination helps manage both postprandial (after-meal) and fasting blood sugar levels, offering all-around glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: STERIS SITAGLIPTIN 50 + METFORMIN 500 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, this medication can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nLow Risk of Hypoglycemia: When used alone or in combination with Metformin, Sitagliptin has a low risk of causing hypoglycemia compared to some other diabetes medications.\nHow to Use STERIS SITAGLIPTIN 50 + METFORMIN 500\nDosage and Administration\nRecommended Dosage: The typical dosage is one tablet taken once or twice daily, depending on your healthcare provider's instructions. The dosage may be adjusted based on individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take the medication regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/steris-sitagliptin-50-metformin-500-134361", "price": 285.0, "discountamount": 85.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Diet", "body", "liver", "Order", "EMAIL", "meals", "water", "amount", "Action", "option", "Support", "ability", "readings", "Low Risk", "Overview", "biguanide", "neuropathy", "one tablet", "overweight", "full glass", "Guidelines", "information", "Optimal Use", "utilization", "cornerstone", "retinopathy", "Adjustments", "Introduction", "Postprandial", "Reduced Risk", "best results", "sterisonline", "instructions", "DPP-4 enzyme", "Hypoglycemia", "sterispharma", "Metformin HCI", "effectiveness", "CALL/WHATSAPP", "Dual Mechanism", "Administration", "typical dosage", "obese patients", "Consistent Use", "treatment plan", "safety profile", "insulin release", "glucagon levels", "DPP-4) inhibitor", "significant role", "Sitagliptin 50mg", "Exercise Adjunct", "excellent adjunct", "incretin hormones", "weight neutrality", "Weight Management", "prolonged activity", "glucose metabolism", "STERIS SITAGLIPTIN", "Recommended Dosage", "modest weight loss", "blood sugar control", "insulin sensitivity", "Diabetes Management", "healthcare provider", "individual response", "combination medication", "cardiovascular disease", "dipeptidyl peptidase-4", "long-term complications", "lifestyle modifications", "Fasting Glucose Control", "Metformin Hydrochloride", "complementary mechanisms", "type 2 diabetes mellitus", "peripheral glucose uptake", "stable blood sugar levels", "other diabetes medications", "Additional Health Benefits", "hepatic glucose production", "gastrointestinal discomfort", "comprehensive glycemic control", "Effective Blood Sugar Management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1468, "imageuri": "https://productimages.withfloats.com/actual/6661a271487c46164ce5354d.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661a271487c46164ce5354d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T11:50:08.381Z", "updatedon": "2024-06-29T05:37:18.286Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/steris-sitagliptin-50-metformin-500-/1468", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "STERIS SITAGLIPTIN 50 + METFORMIN 500 ", "category": "DIABETIC RANGE", "tags": [ "STERIS SITAGLIPTIN 50", "METFORMIN 500", "Sitagliptin (50mg)", "Metformin HCI (500mg)", "Metformin HCl", "Metformin side effects", "Metformin hydrochloride tablet uses", "Metformin Hydrochloride Tablets IP 500mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665db499d91d281c30c715d9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ACARBZONE M 500", "description": "ACARBZONE M 500\nAcarbose (50mg), Metformin (500mg)\nIntroduction to ACARBZONE M 500\nACARBZONE M 500 combines Acarbose 50mg and Metformin 500mg, two powerful antidiabetic medications used to manage type 2 diabetes mellitus. This combination medication helps improve blood sugar control by utilizing complementary mechanisms: Acarbose slows down the digestion and absorption of carbohydrates, while Metformin improves insulin sensitivity and reduces glucose production by the liver. Together, these actions provide comprehensive glycemic control for individuals with type 2 diabetes.\n\nWhat are Acarbose and Metformin?\nOverview of Acarbose\nAcarbose is an alpha-glucosidase inhibitor that works by inhibiting enzymes in the intestines responsible for breaking down carbohydrates into glucose. This slows the digestion process and reduces postprandial (after-meal) blood sugar spikes.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization.\n\nBenefits of ACARBZONE M 500\nEffective Blood Sugar Management\nPostprandial Glucose Control: Acarbose helps reduce blood sugar spikes after meals by slowing carbohydrate digestion.\nBasal Glucose Control: Metformin helps maintain lower fasting blood sugar levels by improving insulin sensitivity and decreasing hepatic glucose production.\nComplementary Mechanisms\nDual Action: The combination of Acarbose and Metformin provides a dual mechanism of action, addressing both postprandial and basal glucose levels for more comprehensive diabetes management.\nSynergistic Effect: Together, these medications enhance each other’s effects, providing better glycemic control than either agent alone.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: ACARBZONE M 500 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining stable blood sugar levels, ACARBZONE M 500 helps reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin may help with weight management by reducing appetite and promoting modest weight loss.\nImproved Lipid Profile: Metformin has been shown to improve lipid profiles, reducing LDL cholesterol and triglycerides while increasing HDL cholesterol.\nHow to Use ACARBZONE M 500\nDosage and Administration\nRecommended Dosage: The typical starting dose of ACARBZONE M 500 is one tablet taken two to three times daily, with meals. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with the first bite of each main meal. This timing helps maximize the effectiveness of both Acarbose and Metformin in controlling blood sugar levels.\nGuidelines for Optimal Use\nConsistent Use: For best results, take ACARBZONE M 500 consistently as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/acarbzone-m-500-133890", "price": 165.0, "discountamount": 49.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Diet", "body", "Order", "EMAIL", "agent", "meals", "liver", "timing", "amount", "actions", "effects", "Support", "enzymes", "readings", "Overview", "appetite", "patients", "biguanide", "main meal", "one tablet", "first bite", "absorption", "neuropathy", "intestines", "Guidelines", "individuals", "Adjustments", "utilization", "information", "Optimal Use", "Dual Action", "retinopathy", "ACARBZONE M", "Introduction", "Reduced Risk", "best results", "sterisonline", "sterispharma", "CALL/WHATSAPP", "carbohydrates", "Lipid Profile", "effectiveness", "triglycerides", "Acarbose 50mg", "dual mechanism", "Administration", "Consistent Use", "treatment plan", "Metformin 500mg", "HDL cholesterol", "LDL cholesterol", "Exercise Adjunct", "Weight Management", "digestion process", "excellent adjunct", "Recommended Dosage", "modest weight loss", "Synergistic Effect", "insulin sensitivity", "healthcare provider", "blood sugar control", "individual response", "basal glucose levels", "Basal Glucose Control", "typical starting dose", "combination medication", "carbohydrate digestion", "cardiovascular disease", "long-term complications", "lifestyle modifications", "complementary mechanisms", "type 2 diabetes mellitus", "meal) blood sugar spikes", "peripheral glucose uptake", "stable blood sugar levels", "hepatic glucose production", "Additional Health Benefits", "alpha-glucosidase inhibitor", "Postprandial Glucose Control", "comprehensive glycemic control", "Effective Blood Sugar Management", "comprehensive diabetes management", "two powerful antidiabetic medications" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1249, "imageuri": "https://productimages.withfloats.com/actual/665db49b947ffd864ebad11e.png", "tileimageuri": "https://productimages.withfloats.com/tile/665db49b947ffd864ebad11e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-03T12:18:33.733Z", "updatedon": "2024-06-03T12:18:33.733Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/acarbzone-m-500/1249", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ACARBZONE M 500", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66541ca7329f8d125c490814", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "AMIDRONE 200", "description": "AMIDRONE 200\nAmiodarone (200mg)\nAMIDRONE 200, containing Amiodarone (200mg), is a highly effective antiarrhythmic medication designed to stabilize heart rhythms. It's particularly crucial for patients with potentially fatal arrhythmias where other treatments might have failed.\n\nUses:\nThis medication is primarily used to treat severe ventricular arrhythmias such as ventricular tachycardia and ventricular fibrillation. It is also effective against atrial fibrillation and other serious supraventricular arrhythmias that do not respond to other medications.\n\nDosage:\nTreatment typically starts with a high initial dose ranging from 800 to 1600 mg daily for 1 to 3 weeks until a response is achieved, followed by a gradual reduction to maintenance levels of 200 to 400 mg per day as directed by a healthcare provider.\n\nSide Effects:\nCommon side effects of AMIDRONE 200 include nausea, fatigue, and tremors. Serious potential side effects involve lung and liver toxicity, vision issues, and skin changes. Long-term use may lead to thyroid dysfunction or neurological effects.\n\nPrecautions:\nPatients on AMIDRONE 200 should have regular monitoring of heart function, liver enzymes, lung function, and thyroid function tests. This medication should be used with caution in combination with other drugs that can affect the heart rhythm. Patients should avoid grapefruit juice and excessive sunlight due to interactions and increased risk of sunburn.\n\nConclusion:\nAMIDRONE 200 is a cornerstone in the management of severe arrhythmias, requiring careful oversight and regular follow-ups to manage its complex side effect profile effectively. It's vital for patients to maintain close communication with their healthcare providers to ensure safe and effective treatment.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 126.0, "discountamount": 38.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "800", "day", "risk", "Uses", "safe", "200mg", "Dosage", "nausea", "1600 mg", "sunburn", "tremors", "fatigue", "AMIDRONE", "patients", "response", "Conclusion", "Amiodarone", "management", "Precautions", "combination", "cornerstone", "other drugs", "interactions", "1 to 3 weeks", "skin changes", "200 to 400 mg", "lung function", "liver enzymes", "vision issues", "heart rhythms", "Long-term use", "liver toxicity", "heart function", "grapefruit juice", "other treatments", "gradual reduction", "fatal arrhythmias", "other medications", "high initial dose", "careful oversight", "maintenance levels", "regular follow-ups", "excessive sunlight", "severe arrhythmias", "regular monitoring", "atrial fibrillation", "Common side effects", "healthcare provider", "effective treatment", "close communication", "thyroid dysfunction", "neurological effects", "thyroid function tests", "ventricular tachycardia", "ventricular fibrillation", "complex side effect profile", "Serious potential side effects", "severe ventricular arrhythmias", "effective antiarrhythmic medication", "other serious supraventricular arrhythmias" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1154, "imageuri": "https://productimages.withfloats.com/actual/667d2d5d000f6c164f095062.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d2d5d000f6c164f095062.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-05-27T05:39:51.591Z", "updatedon": "2024-06-27T09:14:03.7Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//amidrone-200/1154", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Amiodarone (200mg)", "category": "CARDIOLOGYRANGE", "tags": [ "Amiodarone 200 mg uses", "Amiodarone uses", "Amiodarone dosage 200 mg", "Is 200 mg of amiodarone a lot", "Amiodarone 200 mg price", "Amiodarone side effects", "Side effects of amiodarone 200 mg", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68c29ba02244c906e7790e2b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TELAVINCE 300", "description": "TELAVINCE 300 is a high-quality antiviral medication containing Tenofovir Disoproxil Fumarate 300 mg, specifically formulated for the effective management of HIV-1 infection and chronic Hepatitis B in adults and adolescents. Manufactured under strict pharmaceutical standards, TELAVINCE 300 offers consistent, potent, and clinically proven antiviral action, helping to suppress viral replication and improve immune function.\n\nTenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI). It works by interfering with the enzyme reverse transcriptase, which is essential for viral replication in HIV and Hepatitis B viruses. By inhibiting this enzyme, TELAVINCE 300 reduces the amount of virus in the body, helping to prevent further immune system damage and liver complications.\n\n \nKey Indications:\n \n\nTELAVINCE 300 is indicated for:\n\nHIV-1 Infection: In combination with other antiretroviral agents for the treatment of HIV-1 in adults and adolescents (aged 12 years and older, weighing at least 35 kg).\n\nChronic Hepatitis B: For the treatment of chronic hepatitis B virus infection in adults and adolescents with compensated liver disease and evidence of active viral replication.\n\n \nMechanism of Action:\n \nTenofovir Disoproxil Fumarate is a prodrug of tenofovir, which, once absorbed and metabolized in the body, is converted into tenofovir diphosphate, the active form. Tenofovir diphosphate acts as a competitive inhibitor of reverse transcriptase, incorporating itself into the viral DNA chain and causing premature chain termination. This process disrupts the life cycle of the virus, significantly reducing its ability to multiply and spread.\n\n \nDosage and Administration:\n \n\nRecommended Dose for Adults and Adolescents (≥12 years, ≥35 kg): One tablet (300 mg) once daily, preferably with food.\n\nFor HIV Treatment: Administer in combination with other antiretroviral medications as per the treatment regimen.\n\nFor Chronic Hepatitis B: Monotherapy or as part of combination therapy, depending on patient condition and physician's assessment.\n\nDosage adjustments may be required in patients with renal impairment. Close monitoring is recommended for patients with existing kidney disease.\n\n \nKey Benefits of TELAVINCE 300:\n \n\nPotent Antiviral Action: Rapid and sustained suppression of HIV and HBV replication.\nOnce-Daily Dosing: Improves patient compliance and treatment adherence.\n\nBacked by Clinical Research: Proven efficacy in managing viral load and improving immune markers (CD4 count).\n\nTrusted Quality: Manufactured under GMP-certified facilities with stringent quality control processes.\n\nPart of First-Line Therapy: Recommended in various national and international treatment guidelines for HIV and Hepatitis B.\n\n \nSafety and Precautions:\n \n\nRenal Monitoring: Tenofovir may affect kidney function. Routine renal function tests are recommended before and during treatment.\n\nBone Mineral Density: Long-term use may reduce bone mineral density. Consider monitoring in patients at risk of osteopenia or osteoporosis.\n\nHepatic Flare: Discontinuation of therapy in hepatitis B patients may result in severe acute exacerbations. Liver function should be closely monitored post-treatment.\n\nLactic Acidosis and Hepatomegaly: Rare but serious side effects. Patients presenting symptoms such as abdominal pain, fatigue, or difficulty breathing should seek immediate medical attention.\n\n \n\nPossible Side Effects:\n \n\nMost patients tolerate TELAVINCE 300 well. However, some may experience:\n\nNausea\n\nDiarrhea\n\nHeadache\n\nFatigue\n\nRash\n\nDizziness\n\nDecreased bone mineral density\n\nRenal impairment (in rare cases)\n\nIf any side effects persist or worsen, consult a healthcare professional immediately.\n\n \nStorage Instructions:\n \n\nStore in a cool, dry place below 30°C.\n\nProtect from light and moisture.\n\nKeep out of reach of children.\n\n \n\nWhy Choose TELAVINCE 300?\n \n\nTELAVINCE 300 offers a dependable, clinically validated solution for the long-term management of HIV and Hepatitis B. With its once-daily dosing and proven effectiveness, TELAVINCE 300 is an ideal choice for patients and healthcare providers looking for quality, safety, and therapeutic reliability. It is manufactured by a trusted name in healthcare, ensuring every tablet meets global pharmaceutical standards.\n\n \nDisclaimer:\n \n\nThis product description is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor or healthcare provider before starting any medication.", "price": 1480.0, "discountamount": 444.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2179, "imageuri": "https://productimages.withfloats.com/actual/68c29ba3794abb27ab248d73.png", "tileimageuri": "https://productimages.withfloats.com/tile/68c29ba3794abb27ab248d73.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-11T09:51:28.508Z", "updatedon": "2025-09-11T09:51:28.508Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/telavince-300/2179", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Tenofovir Disoproxil Fumarate Tablets ip 300 mg", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }